Medicines and Healthcare products Regulatory Agency
Regulatory Agency
- Alerts, recalls and safety information: medicines and medical devices
- Drug Safety Update
- Yellow Card: Report a problem with a medicine or medical device
- Marketing authorisations and licensing guidance
- Product information about medicines
- Regulating medical devices
- Latest information for patients
- About MHRA
- All MHRA services and information
Featured
News story
Single-dose 7.2mg semaglutide (Wegovy) pen approved to treat adult patients with obesity
As with any medicine, the MHRA will keep the safety and effectiveness of Wegovy under close review.
Press release
MHRA and eBay working in partnership to safeguard public health
MHRA and eBay partnership removes 215 listings of potentially dangerous medicines from the eBay platform highlighting the benefits of private/public working.
Press release
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome
MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome
Press release
MHRA expands AI Airlock programme with a £3.6 million funding boost over three years
The MHRA continues to be at the forefront of innovation and secures multi-year funding to expand its pioneering AI Airlock programme.
Press release
UK and US deepen regulatory cooperation on medical devices, building on wider pharmaceutical partnership
The Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration are strengthening cooperation on medical device regulation, to support faster access to safe, innovative technologies for patients in both countries.
Press release
Sevabertinib approved to treat adults with HER2-positive lung cancer that has spread or cannot be removed by surgery
As with any medicine, the MHRA will keep the safety and effectiveness of sevabertinib under close review.
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA10 South Colonnade
London
E14 4PU
United Kingdom
Telephone (including out of hours):
020 3080 7651
Make a Freedom of Information (FOI) request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom